Crinetics Pharmaceuticals, Inc.
CRNX
株式のランク
#2240
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical... Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
株価
$84.95
最終同期: 2026-09-01
時価総額
$9.00B
変化（1日）
0.00%
変化（1年）
100.12%
国
US
取引 Crinetics Pharmaceuticals, Inc. (CRNX)
カテゴリー
Healthcare
Crinetics Pharmaceuticals, Inc.（CRNX）の営業利益率
October 2026 時点の営業利益率 TTM: -1,302.52%
Crinetics Pharmaceuticals, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は -1,302.52% です。2023 年末時点では -5,547.17% でした。
Crinetics Pharmaceuticals, Inc. の営業利益率の履歴（2016 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | -1,302.52% | -96.01% |
| 2024 | -32,613.47% | 487.93% |
| 2023 | -5,547.17% | 56.52% |
| 2022 | -3,544.06% | -64.53% |
| 2021 | -9,990.91% | -90.54% |
| 2020 | -105,567.61% | 2,239.54% |
| 2019 | -4,512.32% | 281.61% |
| 2018 | -1,182.45% | 164.94% |
| 2017 | -446.31% | -56.51% |
| 2016 | -1,026.15% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | -100.03% |
US
|
|
| -149.01% | -99.89% |
US
|
|
| 25.57% | -100.02% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -100.02% |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。